Sunbird Bio’s Blood Test Accurately Diagnoses Parkinson’s
Sunbird Bio, a biotechnology company focused on neurological disorders and early-stage cancer diagnostics, has unveiled promising data regarding its...
Jon Napitupulu
Scholar Rock to Present New Data from Phase 1 DRAGON Trial at SITC
Scholar Rock, a late-stage biopharmaceutical company specializing in treatments for serious diseases like spinal muscular atrophy (SMA), cardiometabolic disorders,...
Cobenfy™ Long-Term Schizophrenia Data Presented at Psych Congress 2024
Bristol Myers Squibb recently unveiled positive topline results from two Phase 3 open-label trials, EMERGENT-4 and EMERGENT-5. These trials...
Mirum Showcases Livmarli Data at NASPGHAN Meeting
Mirum Pharmaceuticals will participate in the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) annual meeting from...
ChromaDex Corp Q3 2024 Results
ChromaDex Corp. reported strong third-quarter 2024 financial results, marked by record revenue, net income, and adjusted EBITDA. The company...
Koru Medical Systems Data at PODD Conference: Nursing Preference for FreedomEdge® Infusion System
KORU Medical Systems presented data at the 2024 PODD Conference showcasing nurse preference for the KORU FreedomEdge® Infusion System...
Verastem Oncology NDAs Avutometinib for Ovarian Cancer
Verastem Oncology has completed its New Drug Application (NDA) to the U.S. FDA for a combination therapy targeting recurrent...
Synedgen Gets $2.2M for Radiation Countermeasure
Synedgen, Inc., a biotechnology company specializing in gastrointestinal disease treatment, has secured a $2.2 million contract from the Joint...
Lucent Diagnostics’ New Blood Test for Early Alzheimer’s Diagnosis
Lucent Diagnostics has launched LucentAD Complete, a novel multi-marker blood test designed to enhance the detection of Alzheimer’s Disease...
Dynamx Bioadaptor: Superior Results in Complex Coronary Cases
Elixir Medical, a company dedicated to developing innovative treatments for cardiovascular diseases, has released promising data from its INFINITY-SWEDEHEART...